NSE filing, NSE: BAJAJHCARE. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹312.65
- Market cap
- ₹1,053 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 51.1×Sector 46.1×
- Promoter holding
- 58.59%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare delivered strong H1 growth led by a 82% surge in formulations and key new specialty launches.
- Call
- Guides 15% growth
Bajaj Healthcare Results Update
Bajaj Healthcare reported Q2 FY27 revenue of ₹175.9 Crore, up 18.9% YoY. EBITDA stood at ₹32.1 Crore, reflecting a 12.2% YoY increase.
Bajaj Healthcare Other Announcement
Bajaj Healthcare filed its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations for the utilization of preferential issue proceeds.
Bajaj Healthcare Q2 FY27 Results: Net Profit ₹14.1 Cr, Up 27.0% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹175.9 Cr (+18.9% YoY) and net profit of ₹14.1 Cr (+27.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹14.1 Cr · +27.0% YoY
Bajaj Healthcare Acquisition
Bajaj Healthcare received NCLT approval to acquire Genrx Pharmaceuticals Private Limited as a going concern. The entity will become a wholly owned subsidiary.
Bajaj Healthcare Merger & Restructuring Worth ₹14.67 Cr
Bajaj Healthcare Limited has executed a deed of assignment to sell its undertaking located in Dahej Industrial Area, Gujarat, for approximately Rs. 14.67 Crore.
- Value
- ₹14.67 Cr
Other board meeting date announcements
All →INDO SMC Board Meeting Date
INDO SMC Ltd has scheduled a board meeting for 3 November 2026 to consider unaudited financial results for the half-year ended 30 September 2026. The filing also notes the trading window closure, which is not itself a material event.
BNR Udyog Board Meeting Date
BNR Udyog Ltd has scheduled a board meeting for 11 November 2026 to consider unaudited quarterly and half-year results ended 30 September 2026 and the limited review report. This is a prior intimation, so no decisions have been taken yet.
Jindal Worldwide Board Meeting Date
Jindal Worldwide Ltd announces prior intimation of a board meeting on 05 November 2026 to consider unaudited standalone and consolidated results for quarter and half year ended 30 September 2026. The filing is a notice only, with no decisions taken yet.
IKIO Technologies Board Meeting Date
IKIO Technologies has scheduled a board meeting on 5 November 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. This is an advance notice; the results are not yet approved.
Kiri Industries Board Meeting Date
Kiri Industries has scheduled a board meeting on 5 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. This is a future meeting notice, so the results are not yet approved.
Apollo Pipes Board Meeting Date
Apollo Pipes scheduled a board meeting for 5 November 2026 to consider Q2 and half-year results. The trading window reopens on 8 November 2026.